Cartesian Therapeutics Inc. (RNAC) — Free Cash Flow Generation Index
Cartesian Therapeutics Inc. (RNAC) has a Free Cash Flow Generation Index of 0.55x as of September 2024. Free cash flow of $7.49 Million represents 1% of operating cash flow ($13.69 Million). See Cartesian Therapeutics Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cartesian Therapeutics Inc. Free Cash Flow Generation Index (2020–2020)
Historical FCF Generation Index trend for Cartesian Therapeutics Inc. across 1 annual periods. Explore RNAC operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Cartesian Therapeutics Inc. (2020–2020)
Year-by-year Free Cash Flow Generation Index for Cartesian Therapeutics Inc.. For the full company profile including market capitalisation, see Cartesian Therapeutics Inc. stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.98x | $34.07 Million | $34.88 Million | $815.00K | — |